Hasil Pencarian  ::  Simpan CSV :: Kembali

"Sediaan mengapung multi unit famotidin dikembangkan untuk memperpanjang waktu tinggal obat di dalam lambung yang ditujukan untuk pengobatan tukak lambung. Formulasi beads mengapung ini dibuat dengan cara mendispersikan famotidin dan kalsium karbonat ke dalam campuran larutan natrium alginat dan hidroksipropilmetilselulosa (HPMC). Larutan tersebut kemudian diteteskan ke dalam larutan 5% CaCl2 yang mengandung 10% asam asetat dengan menggunakan syringe needle dengan ukuran 22-G, 25-G, dan 27-G. Beads kalsium alginat terbentuk karena terjadinya gelasi ion dengan adanya ion kalsium, sedangkan gas karbon dioksida terbentuk karena terjadinya reaksi antara garam karbonat dengan asam asetat. Terbentuknya gas ini akan menghasilkan poros dan menyebabkan beads dapat mengapung. Pada penelitian ini, beads yang dihasilkan dapat mengapung selama lebih dari 24 jam. Beads dengan ukuran 22-G memiliki penjerapan dan daya mengembang terbesar. Persentasi penjerapan beads 22-G adalah sebesar 11,41% dan mampu mengembang hingga 4 kalinya. Namun sediaan yang dihasilkan tidak dapat dijadikan sebagai sediaan lepas lambat karena profil pelepasan obatnya yang sangat cepat.

---

A multiple-unit-type oral floating dosage form of famotidine was developed to prolong gastric residence time, target peptic ulcer. The floating beads formulations were prepared by dispersing famotidine together with calcium carbonate into a mixture of sodium alginate and hydroxypropyl methylcellulose (HPMC) solution. The resulting solution was dropped through 22-G, 25-G, and 27-G syringe needle into 5% CaCl2 solution containing 10% acetic acid. Calcium alginate beads were formed, as alginate undergoes ionotropic gelation by calcium ions and carbon dioxide develops from the reaction of carbonate salts with acetic acid. The evolving gas permeated, leaving pores, which provided the beads buoyancy. The result of this study, the prepared beads have excellent floating ability over period of 24 hours. The 22-G beads have the largest entrapment efficiency and swelling ability. The percent entrapment efficiency of 22-G beads was 11,41% and swelling up to 4 times. Nevertheless, these beads cannot be used as sustained release dosage form due to its rapidly in releasing drugs."

"[ABSTRAKTablet mengapung lepas lambat membutuhkan eksipien yang berfungsi sebagaimatriks yang mampu mengendalikan lepasnya obat dan menfasilitasipengapungan tablet di lambung. Salah satu eksipien yang berpotensi untuk haltersebut adalah eksipien koproses xanthan gum ? gum akasia yang merupakanhasil modifikasi fisik dari 2 jenis polimer alam, yaitu xanthan gum dan gumakasia. Oleh karena itu, penelitian ini bertujuan untuk memperoleh eksipienkoproses xanthan gum ? gum akasia yang kemudian digunakan sebagai matrikspada formulasi tablet mengapung. Pada penelitian ini dibuat eksipien koprosesxanthan gum ? gum akasia dengan perbandingan 1:1, 1:2, 2:1, 1:3 dan 3:1 daneksipien yang diperoleh dikarakterisasi sifat fisik, kimia, danfungsionalnya.Eksipien-eksipien koproses yang dihasilkan tersebut kemudiandiformulasikan menjadi sediaan tablet mengapung dengan menggunakanfamotidin sebagai model obat. Tablet mengapung yang dihasilkan dievaluasi,antara lain uji kemampuan mengapung serta pelepasan obat dalam medium HClpH 1,2 selama 8 jam. Hasil penelitian menunjukkan bahwa eksipien koprosesyang diperoleh berupa serbuk halus tidak berbau dan berwarna putih keabu-abuan.Selain itu eksipien koproses tersebut memiliki kemampuan mengembang yangbaik, viskositas yang cukup besar dan kekuatan gel yang baik yang cocok untukdigunakan sebagai matriks tablet mengapung. Tablet mengapung F2 yang dibuatdengan menggunakan eksipien koproses Ko-XG-GA 1:2 menunjukkankarakteristik yang terbaik dengan floating lag time 8,33± 0,58 menit dankemampuan mengapung hingga 24 jam. Profil pelepasan famotidin dari tabletmengapung yang diformulasikan dengan eksipien koproses Ko-XG-GA (F1 ? F5)menunjukkan profil pelepasan obat terkendali dengan model kinetika pelepasanorde nol dan dapat digunakan untuk pemakaian selama 32 jam. Dari hasilpenelitian ini dapat disimpulkan bahwa eksipien koproses Ko-XG-GA yangdihasilkan dapat diaplikasikan sebagai matriks sediaan tablet mengapung lepasterkendali.

---

ABSTRACTControlled release floating tablets required excipient which act as a matrix thatcan control the release of active drugs and facilitate the tablet floating in thegastric. One of the potential excipients is a co-processed excipient of xanthan gum? gum acacia, which is a physical modification of 2 natural polymers. Therefore,the aim of this study was to produce co-processed excipients of xanthan gumgumacacia, which were used as matrices in the floating tablet formulations. Inthis study, several co-processed excipients were prepared from xanthan gum andgum acacia in the ratio of 1:1, 1:2, 2:1, 1:3 and 3:1. The obtained excipients werecharacterized physically, chemically, and functionality. The co-processedexcipients were then formulated as the floating tablets using famotidine as a drugmodel. The obtained floating tablets were evaluated in terms of the tablet floatingcapabilities and the drug release in HCl medium pH 1.2 for 8 hours. The resultsshowed the co-processed excipients were fine powder, odorless and greyish whitecolour. The resulted excipients had good swelling index, fairly large viscosity andgood gel strength; hence it was suitable applied as matrices of floating tablets. Thefloating tablets of F2 which was containing the co-processed excipient of Co-XGGA1:2 had shown the best characteristics with 8.33 ± 0.58 minutes of floating lagtime and 24 hours of total floating time. The release study revealed that thefamotidine floating tablets which were using co-processed excipients of Co-XGGA(F1 - F5) as matrices could control drug release with zero order release kineticand could be used for controlled release dosage forms for 32 hours. It can beconcluded that the co-processed excipients of Co-XG-GA could be applied asmatrices in controlled release floating tablets.;Controlled release floating tablets required excipient which act as a matrix thatcan control the release of active drugs and facilitate the tablet floating in thegastric. One of the potential excipients is a co-processed excipient of xanthan gum– gum acacia, which is a physical modification of 2 natural polymers. Therefore,the aim of this study was to produce co-processed excipients of xanthan gumgumacacia, which were used as matrices in the floating tablet formulations. Inthis study, several co-processed excipients were prepared from xanthan gum andgum acacia in the ratio of 1:1, 1:2, 2:1, 1:3 and 3:1. The obtained excipients werecharacterized physically, chemically, and functionality. The co-processedexcipients were then formulated as the floating tablets using famotidine as a drugmodel. The obtained floating tablets were evaluated in terms of the tablet floatingcapabilities and the drug release in HCl medium pH 1.2 for 8 hours. The resultsshowed the co-processed excipients were fine powder, odorless and greyish whitecolour. The resulted excipients had good swelling index, fairly large viscosity andgood gel strength; hence it was suitable applied as matrices of floating tablets. Thefloating tablets of F2 which was containing the co-processed excipient of Co-XGGA1:2 had shown the best characteristics with 8.33 ± 0.58 minutes of floating lagtime and 24 hours of total floating time. The release study revealed that thefamotidine floating tablets which were using co-processed excipients of Co-XGGA(F1 - F5) as matrices could control drug release with zero order release kineticand could be used for controlled release dosage forms for 32 hours. It can beconcluded that the co-processed excipients of Co-XG-GA could be applied asmatrices in controlled release floating tablets.;Controlled release floating tablets required excipient which act as a matrix thatcan control the release of active drugs and facilitate the tablet floating in thegastric. One of the potential excipients is a co-processed excipient of xanthan gum– gum acacia, which is a physical modification of 2 natural polymers. Therefore,the aim of this study was to produce co-processed excipients of xanthan gumgumacacia, which were used as matrices in the floating tablet formulations. Inthis study, several co-processed excipients were prepared from xanthan gum andgum acacia in the ratio of 1:1, 1:2, 2:1, 1:3 and 3:1. The obtained excipients werecharacterized physically, chemically, and functionality. The co-processedexcipients were then formulated as the floating tablets using famotidine as a drugmodel. The obtained floating tablets were evaluated in terms of the tablet floatingcapabilities and the drug release in HCl medium pH 1.2 for 8 hours. The resultsshowed the co-processed excipients were fine powder, odorless and greyish whitecolour. The resulted excipients had good swelling index, fairly large viscosity andgood gel strength; hence it was suitable applied as matrices of floating tablets. Thefloating tablets of F2 which was containing the co-processed excipient of Co-XGGA1:2 had shown the best characteristics with 8.33 ± 0.58 minutes of floating lagtime and 24 hours of total floating time. The release study revealed that thefamotidine floating tablets which were using co-processed excipients of Co-XGGA(F1 - F5) as matrices could control drug release with zero order release kineticand could be used for controlled release dosage forms for 32 hours. It can beconcluded that the co-processed excipients of Co-XG-GA could be applied asmatrices in controlled release floating tablets., Controlled release floating tablets required excipient which act as a matrix thatcan control the release of active drugs and facilitate the tablet floating in thegastric. One of the potential excipients is a co-processed excipient of xanthan gum– gum acacia, which is a physical modification of 2 natural polymers. Therefore,the aim of this study was to produce co-processed excipients of xanthan gumgumacacia, which were used as matrices in the floating tablet formulations. Inthis study, several co-processed excipients were prepared from xanthan gum andgum acacia in the ratio of 1:1, 1:2, 2:1, 1:3 and 3:1. The obtained excipients werecharacterized physically, chemically, and functionality. The co-processedexcipients were then formulated as the floating tablets using famotidine as a drugmodel. The obtained floating tablets were evaluated in terms of the tablet floatingcapabilities and the drug release in HCl medium pH 1.2 for 8 hours. The resultsshowed the co-processed excipients were fine powder, odorless and greyish whitecolour. The resulted excipients had good swelling index, fairly large viscosity andgood gel strength; hence it was suitable applied as matrices of floating tablets. Thefloating tablets of F2 which was containing the co-processed excipient of Co-XGGA1:2 had shown the best characteristics with 8.33 ± 0.58 minutes of floating lagtime and 24 hours of total floating time. The release study revealed that thefamotidine floating tablets which were using co-processed excipients of Co-XGGA(F1 - F5) as matrices could control drug release with zero order release kineticand could be used for controlled release dosage forms for 32 hours. It can beconcluded that the co-processed excipients of Co-XG-GA could be applied asmatrices in controlled release floating tablets.]"